INTRODUCTION
In recent years, prepectoral implant-based breast reconstruction using an acellular dermal matrix (ADM) has become increasingly common. Because of concerns regarding complications from a subpectoral approach, including animation deformity, arm-shoulder morbidity restriction, pain, chest tightness, muscle spasm, and increased recovery time, the implant site has been changed to a prepectoral site with the application of ADM. In the prepectoral approach, the proper use of ADM is important because it can reduce the risk of implant-related complications such as capsular contracture, rippling, palpability, and visibility that can occur when preChan pectoral implant placement is performed alone [
1]. Currently, half of all implant-based reconstructions are performed with the use of an ADM because it improves the aesthetic outcomes by enabling better inframammary fold control, creating a larger new implant pocket in immediate breast reconstruction, and masking the surface irregularities in implant coverage [
2]. However, prepectoral implant placement using ADM for full coverage of the implant requires a much larger amount of ADM than subpectoral implant placement, which uses ADM for covering the inferior pole. However, the access and use of human ADM (HADM) in prepectoral implant placement remain limited due to the more expensive cost than subpectoral implant placement. Instead of using HADM, porcine ADM (PADM) has been used in a variety of surgical fields, including breast implant surgery, after the publication of an experimental study evaluating the use of PADM for dura replacement (XenoDerm; Acelity) in 1999 [
3]. One study reported strong histologic similarity and biocompatibility of PADM equivalent to that of HADM, without showing inferiority in function [
4]. Although PADM is more cost-effective than HADM, data on the use of PADM are limited, and it has not been used extensively in the field of cosmetic breast implant surgery.
We present a comparative study on the safety of PADM, in which we analyzed our experiences and outcomes of PADM-assisted prepectoral breast implant surgery for reconstructive and cosmetic indications. The clinical efficiency was also discussed based on a systematic review and meta-analysis of the complication rates and safety of PADM.
DISCUSSION
In breast surgery, implants have been broadly used for reconstruction following nipple-sparing mastectomy or cosmetic surgery. When using an implant, the surgeon should decide the position of the implant pocket. Opinions on the optimal pocket for a breast implant remain divergent; however, prepectoral pocket placement using ADM has increasingly been implemented in recent years. This approach is simple, fast, and preserves the PMM. Thus, it does not have the disadvantages of subpectoral implant placement. Preserving the PMM was reported to play a major role not only in the simplicity of the operation but also in improving the quality of life (QoL) of patients [
1]. Cattelani et al. [
2] reported that the impairment of upper limb function may persist over the long term, thereby adversely influencing the QoL. They also showed that prepectoral breast reconstruction allowed patients to recover complete function of the upper limb more quickly with more improved QoL than subpectoral procedures. Our results also showed that animation deformity could affect the QoL in terms of aesthetic outcomes. In our study, no patients showed upper limb mobility restriction or animation deformity. This contributed to their satisfaction and QoL.
To reduce the risk of capsular contracture in the prepectoral approach, surgeons have used ADM to completely cover the implant. ADM can also be used to treat and prevent capsular contracture [
13]. In our study, four cases of capsular contracture without recurrence were treated.
Previously, the majority of studies and evidence based on the use of ADM in breast surgery were based on HADM. However, many studies using non-human ADMs derived from bovine pericardium, bovine dermis, or porcine dermis have been recently reported because they showed similar capacities to those of HADM in various surgical fields, including dura repair, ventral hernia, chest wall reconstruction, and breast surgery [
3,
4,
8,
11,
16]. Ball et al. [
11] performed a direct comparison of porcine and bovine ADM (BADM) in implant-based immediate reconstruction and reported that using BADM showed significantly higher rates of skin erythema and a trend toward higher complication rates. PADM was also found to be histologically similar to HADM without being functionally inferior to HADM [
4]. In a comparative study between Alloderm and Strattice, the incidence of seroma was rather high in patients who received Alloderm, which was technically supplemented by Strattice, a PADM developed later, and this finding is thought to have been due to the absence of polarity or basement membrane. Other complications were reported similarly [
6]. For this reason, we used a prepectoral implant location for PADM for the first time in Korea.
The use of PADM has several advantages compared to HADM. First, PADM is more economical and easier to supply than HADM. Second, it can avoid ethical conflicts because it uses a non-human dermal matrix. Third, the incidence of complications associated with the use of PADM is not high compared to HADM. In terms of cost, Cattelani et al. [
2] reported that ADM-assisted prepectoral breast reconstruction had economic superiority not only to tissue expander procedures but also to the subpectoral implant location when considering the significantly lower rate of requiring a second operation to achieve symmetry. Since the plane of breast implant placement in Korea does not make a difference in cost, even if it is covered by insurance, prepectoral implant placement using HADM for full implant coverage is extremely expensive. However, PADM is more economical. Assuming that the same size ADM is used for complete implant coverage, which is about 30×20 cm, the price of PADM (about $7,000) is almost one-third that of HADM (about $24,300). Unfortunately, only HADM is covered by health insurance in Korea and PADM is not. Nevertheless, it still has an economical advantage over HADM even after receiving health insurance benefits. This could be a new option for cosmetic reoperation patients who are paying for the procedure without insurance coverage. Furthermore, patients with reconstructive indications may benefit economically from fewer reoperations [
21,
24].
The results of the comparative study analyzing the effect of PADM showed that the postoperative overall complication rate in our study was 14%, which was lower than that in other studies. In our study, complications did not occur in the CBS group or the DIBR group. In contrast, the incidence of complications was relatively high in the IIBR group in our study. This difference might have been exaggerated due to the small number of cases. There were no major complications such as implant loss or explantation or implant exposure requiring hospitalization or reoperation. Compared to other studies, complications related to PADM such as implant exposure and capsular contracture did not occur in the total group. Infection, skin necrosis, and implant loss also did not occur in the CBS group. Thus, the use of PADM during breast surgery is expected to be helpful in this field. In a systematic review of the literature, high complication rates (incidence of 50% or higher) after PADM surgery were observed in three studies related to IIBR. Dikman et al. [
22] performed a retrospective study on the use of Strattice in single-stage breast reconstruction and reported that the complication rate was rather high at 78% (seroma, 21%; skin necrosis, 20%). The reoperation rate was also high at 23%. The most obvious factors influencing complications were related to the patients’ choices. In particular, those who received radiation therapy and smokers were more likely to undergo reoperation. Other causes included the quality of the skin flap after mastectomy and the learning curve for the surgeon’s ADM application. Two other studies by Mazari et al. [
10] and Ball et al. [
11] compared Strattice and SurgiMend in IIBR. The most common complication was also seroma in one study. In that study, the cause of seroma was reported to be the high percentage of patients undergoing axillary surgery. Other complications such as implant loss, ADM loss, and reoperation could be due to the learning curve. In another study, the incidence of skin erythema and complications were significantly high, possibly due to higher mastectomy breast weight in the Strattice group.
Several limitations of our study should be noted. First, our study included a small number of cases and a short-term follow-up for complications. The proportion of complications tended to increase. This might have been because the number of cases in our study was small, and the complications were mostly concentrated in the IIBR group. Recruitment of large patient populations and long-term follow-up are needed for further analysis. Complications that require long-term follow-up, such as capsular contracture, may also increase over time, and we were unable to evaluate that possibility in the current study. Second, although a subgroup analysis was performed, there was substantial heterogeneity in the meta-analysis due to the clinical diversity in the studies included. This was the result of the limited selection of papers from which to obtain maximum information on complications and safety in breast implant surgery with PADM. The cause of such heterogeneity may also reflect the technological advances over time from 2012 to 2019 and that these studies were from several different countries, with different study designs and patient groups. Among several studies comparing HADM, PADM, and BADM, only PADM was extracted for analysis. In subgroup analysis, there were inevitably overlapping studies in the study design. For example, one study compared two or more groups of CBS, IIBR, and DIBR, and some were divided into one-stage and two-stage breast reconstruction in IIBR. The timing of reconstruction may have a somewhat different effect on PADM. This possibility requires further research. Third, radiotherapy, chemotherapy, and skin diseases that would be confused with inflammation, immune diseases, and the use of topical steroids were not included in the data analysis, so the possible effect of these factors on safety outcomes was not identified.
Our literature review and cases support the effectiveness of PADM-assisted prepectoral breast implant surgery. To the best of our knowledge, this is the first case series report of PADM-assisted prepectoral breast implant surgery in Korea. Our single-center complication rates were comparable to those of other studies. The overall complication rate was relatively low. PADM-assisted prepectoral breast implant surgery was particularly effective in revision CBS and DIBR. In IIBR, PADM was helpful in preventing implant loss, implant exposure, and capsular contracture. PADM-assisted prepectoral breast implant surgery for cosmetic and reconstructive indications had financial benefits due to its lower resource usage compared to HADM. It also provided fewer ethical conflicts and lower complication rates compared to HADM and avoided the disadvantages of subpectoral placement by detaching the PMM. However, the results of the studies included in the systematic review should be interpreted cautiously due to the influence of publication bias and substantial heterogeneity. To summarize, when consulting with patients about breast implant surgery, PADM-assisted prepectoral implant placement could be another option besides the traditional technique if it is provided with appropriate patient selection and an improved learning curve.